• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇增强 A 和抑制 A 腺苷受体信号在 HeLa 和 SH-SY5Y 细胞中的作用:其抗肿瘤作用的潜在机制。

Resveratrol enhances A and hinders A adenosine receptors signaling in both HeLa and SH-SY5Y cells: Potential mechanism of its antitumoral action.

机构信息

Department of Inorganic and Organic Chemistry and Biochemistry, Faculty of Chemical and Technological Sciences, School of Medicine of Ciudad Real, Regional Center of Biomedical Research (CRIB), University of Castilla-La Mancha (UCLM), Ciudad Real, Spain.

出版信息

Front Endocrinol (Lausanne). 2022 Nov 3;13:1007801. doi: 10.3389/fendo.2022.1007801. eCollection 2022.

DOI:10.3389/fendo.2022.1007801
PMID:36407311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9669387/
Abstract

Despite great efforts, effective treatment against cancer has not yet been found. However, natural compounds such as the polyphenol resveratrol have emerged as promising preventive agent in cancer therapy. The mode of action of resveratrol is still poorly understood, but it can modulate many signaling pathways related to the initiation and progression of cancer. Adenosinergic signaling may be involved in the antitumoral action of resveratrol since resveratrol binds to the orthosteric binding site of adenosine A receptors and acts as a non-selective agonist for adenosine receptors. In the present study, we measured the impact of resveratrol treatment on different adenosinergic pathway components (i.e. adenosine receptors levels, 5'-nucleotidase, adenosine deaminase, and adenylyl cyclase activities, protein kinase A levels, intracellular adenosine and other related metabolites levels) and cell viability and proliferation in HeLa and SH-SY5Y cell lines. Results revealed changes leading to turning off cAMP signaling such as decreased levels of A receptors and reduced adenylyl cyclase activation, increased levels of A receptors and increased adenylyl cyclase inhibition, and lower levels of PKA. All these changes could contribute to the antitumoral action of resveratrol. Interestingly, these effects were almost identical in HeLa and SH-SY5Y cells suggesting that resveratrol enhances A and hinders A adenosine receptors signaling as part of a potential mechanism of antitumoral action.

摘要

尽管付出了巨大努力,但仍未找到有效的癌症治疗方法。然而,多酚白藜芦醇等天然化合物已成为癌症治疗中很有前途的预防剂。白藜芦醇的作用机制仍知之甚少,但它可以调节与癌症发生和进展相关的许多信号通路。腺苷能信号可能参与白藜芦醇的抗肿瘤作用,因为白藜芦醇结合到腺苷 A 受体的正位结合位点,并作为腺苷受体的非选择性激动剂。在本研究中,我们测量了白藜芦醇处理对不同腺苷能途径成分(即腺苷受体水平、5'-核苷酸酶、腺苷脱氨酶和腺苷酸环化酶活性、蛋白激酶 A 水平、细胞内腺苷和其他相关代谢物水平)以及 HeLa 和 SH-SY5Y 细胞系的细胞活力和增殖的影响。结果显示,导致 cAMP 信号关闭的变化,如 A 受体水平降低和腺苷酸环化酶激活减少、A 受体水平升高和腺苷酸环化酶抑制增加以及蛋白激酶 A 水平降低。所有这些变化都可能有助于白藜芦醇的抗肿瘤作用。有趣的是,这些效应在 HeLa 和 SH-SY5Y 细胞中几乎相同,表明白藜芦醇增强 A 并抑制 A 腺苷受体信号,作为抗肿瘤作用的潜在机制的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/7e09276d9433/fendo-13-1007801-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/0fab80d15169/fendo-13-1007801-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/e08e3a7b37b9/fendo-13-1007801-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/36b5b4ca68fb/fendo-13-1007801-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/98af4bfde76b/fendo-13-1007801-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/2f8ee59433fe/fendo-13-1007801-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/90d99ea3181b/fendo-13-1007801-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/c6f7028204a9/fendo-13-1007801-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/9650aa863387/fendo-13-1007801-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/df0385e3de31/fendo-13-1007801-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/7e09276d9433/fendo-13-1007801-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/0fab80d15169/fendo-13-1007801-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/e08e3a7b37b9/fendo-13-1007801-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/36b5b4ca68fb/fendo-13-1007801-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/98af4bfde76b/fendo-13-1007801-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/2f8ee59433fe/fendo-13-1007801-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/90d99ea3181b/fendo-13-1007801-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/c6f7028204a9/fendo-13-1007801-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/9650aa863387/fendo-13-1007801-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/df0385e3de31/fendo-13-1007801-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8360/9669387/7e09276d9433/fendo-13-1007801-g010.jpg

相似文献

1
Resveratrol enhances A and hinders A adenosine receptors signaling in both HeLa and SH-SY5Y cells: Potential mechanism of its antitumoral action.白藜芦醇增强 A 和抑制 A 腺苷受体信号在 HeLa 和 SH-SY5Y 细胞中的作用:其抗肿瘤作用的潜在机制。
Front Endocrinol (Lausanne). 2022 Nov 3;13:1007801. doi: 10.3389/fendo.2022.1007801. eCollection 2022.
2
Resveratrol Modulates and Reverses the Age-Related Effect on Adenosine-Mediated Signalling in SAMP8 Mice.白藜芦醇调节和逆转 SAMP8 小鼠衰老相关的腺苷介导信号作用。
Mol Neurobiol. 2019 Apr;56(4):2881-2895. doi: 10.1007/s12035-018-1281-8. Epub 2018 Aug 1.
3
Effect of Xanthohumol, a Bioactive Natural Compound from Hops, on Adenosine Pathway in Rat C6 Glioma and Human SH-SY5Y Neuroblastoma Cell Lines.黄腐酚,一种来自啤酒花的生物活性天然化合物,对大鼠 C6 神经胶质瘤和人 SH-SY5Y 神经母细胞瘤细胞系中的腺苷途径的影响。
Nutrients. 2024 Jun 6;16(11):1792. doi: 10.3390/nu16111792.
4
Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells.白藜芦醇通过腺苷能信号传导对C6胶质瘤细胞的抗肿瘤作用
Front Neurosci. 2021 Sep 1;15:702817. doi: 10.3389/fnins.2021.702817. eCollection 2021.
5
Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells.NG108 - 15细胞中A2a和A2b腺苷受体共表达及脱敏的证据。
Biochem Pharmacol. 1998 Mar 1;55(5):595-603. doi: 10.1016/s0006-2952(97)00466-8.
6
Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells.腺苷A1和A2A受体的激活调节稳定转染的人神经母细胞瘤细胞中多巴胺D2受体诱导的反应。
J Neurochem. 2000 Jan;74(1):432-9. doi: 10.1046/j.1471-4159.2000.0740432.x.
7
The antioxidant resveratrol acts as a non-selective adenosine receptor agonist.抗氧化剂白藜芦醇作为一种非选择性的腺苷受体激动剂。
Free Radic Biol Med. 2019 May 1;135:261-273. doi: 10.1016/j.freeradbiomed.2019.03.019. Epub 2019 Mar 18.
8
A dominant negative mutant of the G protein-coupled receptor kinase 2 selectively attenuates adenosine A2 receptor desensitization.G蛋白偶联受体激酶2的显性负性突变体选择性减弱腺苷A2受体脱敏。
Mol Pharmacol. 1997 Jun;51(6):991-8. doi: 10.1124/mol.51.6.991.
9
Protein kinase C regulates adenosine A2a receptor mRNA expression in SH-SY5Y cells.蛋白激酶C调节SH-SY5Y细胞中腺苷A2a受体mRNA的表达。
Eur J Pharmacol. 1997 Oct 1;336(1):71-80. doi: 10.1016/s0014-2999(97)01194-1.
10
Enhanced expression of G protein-coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist-induced desensitization.G蛋白偶联受体激酶2的表达增强选择性地增加了A2A腺苷受体对激动剂诱导脱敏的敏感性。
Br J Pharmacol. 1998 Sep;125(2):347-56. doi: 10.1038/sj.bjp.0702081.

引用本文的文献

1
Mitochondrial Localization and Function of Adenosine Receptors.腺苷受体的线粒体定位与功能
Int J Biol Sci. 2025 Feb 10;21(5):1874-1893. doi: 10.7150/ijbs.101930. eCollection 2025.
2
Effect of Xanthohumol, a Bioactive Natural Compound from Hops, on Adenosine Pathway in Rat C6 Glioma and Human SH-SY5Y Neuroblastoma Cell Lines.黄腐酚,一种来自啤酒花的生物活性天然化合物,对大鼠 C6 神经胶质瘤和人 SH-SY5Y 神经母细胞瘤细胞系中的腺苷途径的影响。
Nutrients. 2024 Jun 6;16(11):1792. doi: 10.3390/nu16111792.
3
Resveratrol Inhibits VDAC1-Mediated Mitochondrial Dysfunction to Mitigate Pathological Progression in Parkinson's Disease Model.

本文引用的文献

1
cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.cAMP 信号在癌症中的作用:以 PKA-CREB 和 EPAC 为中心的方法。
Cells. 2022 Jun 24;11(13):2020. doi: 10.3390/cells11132020.
2
Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data.靶向 A3 腺苷受体的药物:人体临床研究数据。
Molecules. 2022 Jun 8;27(12):3680. doi: 10.3390/molecules27123680.
3
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.癌症中的 ATP 和腺苷代谢:治疗增益的探索。
白藜芦醇抑制电压依赖性阴离子通道1介导的线粒体功能障碍以减轻帕金森病模型中的病理进展。
Mol Neurobiol. 2025 Jun;62(6):6636-6654. doi: 10.1007/s12035-024-04234-0. Epub 2024 May 31.
4
CD73-positive pediatric urethral mesenchymal stem-like cell-derived small extracellular vesicles stimulate angiogenesis.CD73阳性的小儿尿道间充质干细胞样细胞衍生的小细胞外囊泡刺激血管生成。
Regen Ther. 2023 Dec 14;25:77-84. doi: 10.1016/j.reth.2023.12.002. eCollection 2024 Mar.
5
Identification of microRNAs implicated in modulating resveratrol-induced apoptosis in porcine granulosa cells.鉴定参与调控白藜芦醇诱导猪颗粒细胞凋亡的微小RNA
Front Cell Dev Biol. 2023 May 5;11:1169745. doi: 10.3389/fcell.2023.1169745. eCollection 2023.
Pharmacol Rev. 2022 Jul;74(3):797-822. doi: 10.1124/pharmrev.121.000528.
4
Correlation of receptor density and mRNA expression patterns in the human cerebral cortex.人脑皮层中受体密度与 mRNA 表达模式的相关性。
Neuroimage. 2022 Aug 1;256:119214. doi: 10.1016/j.neuroimage.2022.119214. Epub 2022 Apr 19.
5
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity.以 AB680(Quemliclustat)靶向 CD73,一种新型有效的小分子 CD73 抑制剂,恢复免疫功能并促进抗肿瘤免疫。
Mol Cancer Ther. 2022 Jun 1;21(6):948-959. doi: 10.1158/1535-7163.MCT-21-0802.
6
Adenosine-A2A Receptor Pathway in Cancer Immunotherapy.癌症免疫治疗中的腺苷 - A2A 受体通路
Front Immunol. 2022 Mar 21;13:837230. doi: 10.3389/fimmu.2022.837230. eCollection 2022.
7
Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux.白藜芦醇通过双重抑制 AKT 和自噬通量使乳腺癌对 PARP 抑制剂他拉唑帕尼敏感。
Biochem Pharmacol. 2022 May;199:115024. doi: 10.1016/j.bcp.2022.115024. Epub 2022 Mar 31.
8
Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer.癌中的腺苷代谢酶、腺苷激酶和腺苷脱氨酶。
Biomolecules. 2022 Mar 8;12(3):418. doi: 10.3390/biom12030418.
9
Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells.白藜芦醇诱导获得性耐药癌细胞再敏化的分子基础。
Nutrients. 2022 Feb 7;14(3):699. doi: 10.3390/nu14030699.
10
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?当前的腺苷能疗法:癌细胞将何去何从?
Int J Mol Sci. 2021 Nov 22;22(22):12569. doi: 10.3390/ijms222212569.